The Weekly Edge
Join free
Menu

Feed / Deals & M&A

Kalshi launches drug trial and regulatory decision contracts

By The Weekly Edge desk ·

Summary

BNLData reported that Kalshi introduced contracts related to medicine trials and regulatory decisions. The US offering includes contracts on drug approvals involving Sanofi and Gilead Sciences.

Why it matters

The products extend Kalshi’s event contracts into biotechnology and medicine regulation.

Read the original at BNLData

EntityKalshi
TypeCompany
Entries310
Main marketsUSA, UK
Enforcement & compliance75
Licences & markets3
Deals & M&A51
Fines recorded? 35,000; USD 35,000
Latest16 Oct 2026
Entity mapUSAKalshi
Entities and relations reported in this entry and our coverage.

Request a correction / right of reply

Connected stories

Linked through shared companies, regulators and people, or one step further through the graph.

ShareLinkedInX